Robert Ruffolo, Ph.D.

Chairman
Aragen Biosciences

Robert Ruffolo is currently serving as chairman of Aragen Biosciences and managing director of Ruffolo Consulting, LLC, a consulting company for the pharmaceutical and biotechnology industries. He is the former president of research and development of Wyeth Pharmaceuticals, now Pfizer. At Wyeth, he also served as chief scientific officer and corporate senior vice president. Prior to Wyeth, Ruffolo held executive positions at companies such as Eli Lilly & Co. and SmithKline Beecham Pharmaceuticals. Throughout his career, Ruffolo and his teams have successfully brought to market 37 new drugs. He also has published over 500 papers and edited 15 books. He received a Bachelor of Science in pharmacy and his Ph.D. in pharmacology, both from The Ohio State University.